Toshimi Okada

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito et al. · Journal of Lipid Research · 2003 · 46 citations · Full text

Synthesis and Evaluation of Novel Pyrimido-Acridone, -Phenoxadine, and -Carbazole as Topoisomerase II Inhibitors

Junichi Kamata, Toshimi Okada, Yoshihiko Kotake et al. · Chemical and Pharmaceutical Bulletin · 2004 · 39 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +17

E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models

Saori Watanabe Miyano, Yuji Yamamoto, Kotaro Kodama et al. · Molecular Cancer Therapeutics · 2016 · 36 citations · Full text

Chemoprevention Strategy, Tyrosine Kinase Activities, Tumor Biology +18

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

Hironobu Hiyoshi, Mamoru Yanagimachi, Masashi Ito et al. · European Journal of Pharmacology · 2001 · 30 citations

Lipid Synthesis, Biochemistry, Medicine +6

Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.

Katsuji Nakamura, Hiroyuki Sugumi, Atsumi Yamaguchi et al. · PubMed · 2002 · 26 citations

Antitumor Activity, Chemoprevention Strategy, Pharmacotherapy +17